GlassScriptPhysician profile
Jacob Ryan Bolling
NPI 1942822911
$2,911.47
in general payments reported to CMS, 2019-2025
15 companies · $325 in 2025
The $325 reported for 2025 was more than what a typical Podiatrist provider received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $55.34 · 2021: $334 · 2022: $1,832 · 2023: $177 · 2024: $190 · 2025: $325.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $691.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $690.78 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kairos Surgical INC | $1,215.50 | 2022 | |
| Organogenesis INC. | $531.30 | 2021-2023 | Puraply |
| Convatec INC. | $278.12 | 2021-2024 | |
| Smith+Nephew, INC. | $193.05 | 2021-2022 | |
| Avita Medical Americas, LLC | $136.87 | 2025 | Cohealyx, Recell, Permeaderm |
| Reapplix INC. | $135.96 | 2025 | 3c Patch Kit - Box |
| Stryker Corporation | $119.16 | 2020-2025 | Augment Injectable |
| Orthofix Medical, INC. | $95.08 | 2022-2024 | Physio-Stim |
| Integra Lifesciences Corporation | $67.00 | 2021 | |
| Averitas Pharma INC. | $35.09 | 2024-2025 | Qutenza |
| Treace Medical Concepts, INC. | $24.44 | 2023 | |
| Medela LLC | $21.57 | 2022 | |
| Paratek Pharmaceuticals, INC. | $21.05 | 2024 | Nuzyra |
| Musculoskeletal Transplant Foundation INC. | $19.85 | 2021 | |
| Bioventus LLC | $17.43 | 2023 | Sonicone Clinic |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jacob Bolling listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.